Diagnostics

Robust demand, stable pricing to keep diagnostics volumes strong in FY27

Brokerages expect diagnostic majors to sustain volume growth through FY27, aided by robust demand and stable pricing, though the recent stock rally may cap upside

Robust demand, pricing to keep volumes strong for diagnostics sector

Brokerages expect listed diagnostics majors to maintain volume growth through FY27, helped by stable pricing, B2C demand and operating leverage

Molbio Diagnostics hits 20% upper circuit on heavy volume; up 35% in 2 days

Molbio Diagnostics' share price was locked at the 20% upper circuit at ₹1,509.70 on the BSE, soaring 87% against its IPO price of ₹807 per share.

PE pivots to MedTech as hospital valuations soar; diagnostics gains

Private equity investors are diversifying into MedTech and diagnostics as rising hospital valuations temper deal appetite, even as India's healthcare sector continues to attract strong capital inflows

Dr Lal PathLabs soars 11%, hits 52-week high on huge volumes; here's why

Care Ratings expects Dr Lal PathLabs' revenue to grow by 11-12 per cent per annum in the near-to-medium term driven by organic demand growth, its expanding geographical presence and new initiatives.

Sanofi unveils AI-powered platform for early rare disease detection

Sanofi's AI-powered AccelRare platform aims to help doctors identify rare diseases faster and improve referrals to specialist treatment centres in India

Results preview: Pharma growth steady in Q4, but US drag weighs on margins

India's pharma and healthcare firms may post steady Q4 revenue growth, but weak US generics and rising costs are likely to keep margins under pressure

Diagnostics stocks favoured on Q4 optimism amid strong volume growth

Sector to outshine healthcare peers as higher volumes, steady realisations will boost revenue and profit, say analysts

Torrent Group forays into diagnostics with large national reference lab

Torrent Group has entered the diagnostics sector with a 100,000 sq ft national reference lab in Navi Mumbai, marking a long-term push into high-end, specialised testing amid industry consolidation

Next phase of growth is about improving utilisation: Surendran Chemmenkotil

In a video-interview with Sohini Das, Surendran Chemmenkotil, Managing Director of Metropolis Healthcare, speaks about the company's FY27 network expansion strategy

Thyrocare Technologies shares fall 7% on Q3 results; check key numbers here

Thyrocare reported a strong performance for the Q3FY26, with consolidated profit after tax (PAT) after exceptional items rising 80 per cent to ₹34.07 crore from ₹18.94 crore in the year-ago period

India's diagnostics pivots to precision tests as high-value segments grow

Industry leaders say demand for these higher-value tests aimed at early disease detection, personalised treatment and long-term health management has been expanding far faster than routine pathology

HDFC Sec turns bullish on Dr Lal PathLabs; upgrades to 'Buy'; raises target

Dr Lal PathLabs is focusing on innovation, including new wellness packages and high-end, super-speciality tests, with a focus on capturing prescription shares

Rabies fear in UP: Can milk from infected animal transmit the deadly virus?

A suspected rabies case in a buffalo sent panic through a UP village, with hundreds rushing for vaccines after learning funeral raita was made from its milk. But was the fear justified?

Preventive, precision testing spurs a bigger dose of diagnostics chains

Diagnostic chains are expanding laboratories, integrated centres and collection networks as demand grows for preventive, genomics-led and precision testing across India

Fittr eyes preventive healthcare, plans to set up diagnostic labs: CEO

Fitness firm Fittr is moving towards providing a holistic preventive healthcare service, combining diagnostics with doctor consultations, to target non-communicable diseases, according to its founder and CEO Jitendra Chouksey. The firm has earmarked investment of up to Rs 15 crore to set up company-owned diagnostic laboratories in five metro cities, while also collaborating with partners to expand its lab network to 5,000 pin codes across India, Chouksey told PTI. "We are moving towards a preventive healthcare ecosystem, where we are combining diagnostics with doctor consultations, along with coaching and wearable monitoring, to address one of the biggest pain points in the country today, which is the growing number of NCD (non-communicable diseases) deaths, which are happening in the country," he said. Earlier, Fittr operated primarily as a fitness company, where it used to render nutrition and training services with the help of its coaches, he noted. Chouksey was responding to a

India's diagnostics market shifts to preventive, precision testing in 2025

India's diagnostics sector is seeing a strong shift towards preventive and precision-led testing in 2025, driven by rising demand for proactive health checks and faster genomic diagnostics

Vijaya Diagnostic Centre soars 11% on heavy volumes in range bound market

India's diagnostic services market is expected to maintain double-digit growth (~12% CAGR) by FY30, driven by rising preventive healthcare awareness and expanding health insurance coverage.

Rising demand for GLP-1 weight-loss drugs reshaping diagnostics market

As GLP-1-based weight-loss and diabetes therapies gain popularity, India's diagnostics market is seeing a sharp rise in metabolic testing

Budget: Nathealth asks for ₹50k cr infra fund, tax SOPs for health checkups

Innovation fund for deep tech collabs, setting up of labs and 100% deduction on capex under section 35 AD of IT Act among key demands